Click here to read the complete article.
Abstract Title:Cynaroside ameliorates methotrexate-induced enteritis in rats through inhibiting NLRP3炎性体激活。
摘要来源:
前免疫。 2024; 15:1405084。 EPUB 2024 5月21日。PMID: 38835771 38835771 Zhang, Xuhua Liang, Lin Chen, Dezhu Zhang, Ruina Zhou, Ihsan Ali, Xuansheng Hu, Haihua Zhang, Min Chengp>Article Affiliation:
Wuying Lang
Abstract:INTRODUCTION: Cynaroside具有各种生物学特性,包括抗炎,抗病毒,抗肿瘤和心脏保护作用。然而,它参与甲氨蝶呤(MTX)诱导的肠道炎症仍然不充分理解。因此,我们研究了氰糖苷对MTX诱导的肠道炎症及其潜在机制的影响。
方法:
RESULTS: Administration of 7 mg/kg MTX resulted in decreased daily food intake, increased weight loss, and elevated disease activity大鼠的索引。相反,用20或40 mg/kg的氰化物治疗改善了体重和每日食物摄入的减少,并抑制了疾病活动指数中MTX诱导的升高。值得注意的是,以20或40 mg/kg的形式给药cynaroside抑制了炎症细胞浸润,增强的杯状细胞数量,肿瘤坏死因子-α,白介素(IL)-1β和IL-18的血清水平降低,以及CD668阳性细胞速率以及MTX-MTX-诱导的CD68阳性细胞速率。 Furthermore, cynaroside downregulated the expression levels of NLRP3, cleaved caspase 1, and cleaved IL-1βin MTX-induced rats.
DISCUSSION: Collectively, our findings indicated that cymaroside alleviates intestinal inflammatory injury by inhibiting the activation of MTX诱导的大鼠中的NLRP3炎症体。